Foundation Medicine, Inc. And Flatiron Health Collaborate To Develop First-in-Class Data Platform To Accelerate Precision Medicine For Cancer

CAMBRIDGE, Mass. & NEW YORK--(BUSINESS WIRE)--Foundation Medicine, Inc. (NASDAQ:FMI) and Flatiron Health today announced a strategic collaboration to develop a unique, proprietary cloud-based information platform combining genomic and clinical treatment and outcomes data to significantly advance the field of precision medicine for cancer.

Help employers find you! Check out all the jobs and post your resume.

MORE ON THIS TOPIC